Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis

Copyright 2001 Academic Press.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 98(2001), 1 vom: 01. Jan., Seite 125-32
1. Verfasser: Kim, M K (VerfasserIn)
Weitere Verfasser: Pan, X Q, Huang, Z Y, Hunter, S, Hwang, P H, Indik, Z K, Schreiber, A D
Format: Aufsatz
Sprache:English
Veröffentlicht: 2001
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, U.S. Gov't, P.H.S. Enzyme Precursors Immunoglobulin gamma-Chains Intracellular Signaling Peptides and Proteins Receptors, IgG Protein-Tyrosine Kinases EC 2.7.10.1 SYK protein, human EC 2.7.10.2 Syk Kinase
LEADER 01000naa a22002652 4500
001 NLM110552628
003 DE-627
005 20231222153727.0
007 tu
008 231222s2001 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0369.xml 
035 |a (DE-627)NLM110552628 
035 |a (NLM)11141335 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Kim, M K  |e verfasserin  |4 aut 
245 1 0 |a Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis 
264 1 |c 2001 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 22.02.2001 
500 |a Date Revised 24.11.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright 2001 Academic Press. 
520 |a Receptors for the constant region of IgG, Fc gamma receptors, are expressed on the surface of hematopoietic cells, where they mediate signaling events, such as phagocytosis, essential for host defense. Fc gamma receptors also play a role in the pathophysiology of autoimmune diseases. We have demonstrated that members of each of the three classes of human Fc gamma receptors, Fc gamma RI, Fc gamma RII, and Fc gamma RIII, mediate phagocytosis, but that important differences exist in their requirements for phagocytic signaling. For example, the Fc gamma receptors Fc gamma RI and Fc gamma RIIIA induce signaling largely by association with a gamma subunit containing a conserved cytoplasmic motif (ITAM) whose tyrosines are phosphorylated following receptor stimulation. Fc gamma RIIA contains a similar motif in its own cytoplasmic domain and does not require the gamma chain for phagocytic signaling. The tyrosine kinase Syk associates with the cytoplasmic domain of both the Fc gamma receptor gamma chain and Fc gamma RIIA and is required for phagocytosis by both Fc gamma receptor systems. To elucidate the differences in phagocytic signaling by the gamma chain and Fc gamma RIIA, we investigated the requirements for Fc gamma receptor/Syk co-immunoprecipitation, tyrosine phosphorylation, and phagocytosis. Both Fc gamma RIIA and the human gamma chain contain a tyrosine seven amino acids upstream of the ITAM motif. We observed that the upstream tyrosine plays a role in Fc gamma RIIA phagocytic signaling but is not involved in phagocytic signaling by the human gamma chain. Our data also indicate that the two ITAM tyrosines of the human gamma chain and Fc gamma RIIA do not contribute equally to Fc gamma receptor association with Syk kinase and phagocytic signaling. The data indicate that the carboxy-terminal tyrosine of the receptor cytoplasmic domain is especially important both for the interaction with Syk kinase and for phagocytosis. Elucidating such differences in gamma chain and Fc gamma RIIA signaling may be valuable in designing strategies for therapeutic intervention in hematopoietic and immunological disorders 
650 4 |a Journal Article 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
650 7 |a Enzyme Precursors  |2 NLM 
650 7 |a Immunoglobulin gamma-Chains  |2 NLM 
650 7 |a Intracellular Signaling Peptides and Proteins  |2 NLM 
650 7 |a Receptors, IgG  |2 NLM 
650 7 |a Protein-Tyrosine Kinases  |2 NLM 
650 7 |a EC 2.7.10.1  |2 NLM 
650 7 |a SYK protein, human  |2 NLM 
650 7 |a EC 2.7.10.2  |2 NLM 
650 7 |a Syk Kinase  |2 NLM 
650 7 |a EC 2.7.10.2  |2 NLM 
700 1 |a Pan, X Q  |e verfasserin  |4 aut 
700 1 |a Huang, Z Y  |e verfasserin  |4 aut 
700 1 |a Hunter, S  |e verfasserin  |4 aut 
700 1 |a Hwang, P H  |e verfasserin  |4 aut 
700 1 |a Indik, Z K  |e verfasserin  |4 aut 
700 1 |a Schreiber, A D  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 98(2001), 1 vom: 01. Jan., Seite 125-32  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:98  |g year:2001  |g number:1  |g day:01  |g month:01  |g pages:125-32 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 98  |j 2001  |e 1  |b 01  |c 01  |h 125-32